OSO Trademark

Trademark Overview

On Thursday, June 10, 2021, a trademark application was filed for OSO with the United States Patent and Trademark Office. The USPTO has given the OSO trademark a serial number of 90766032. The federal status of this trademark filing is REGISTERED as of Tuesday, March 12, 2024. This trademark is owned by Hollister Incorporated. The OSO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of clinical trials
oso

General Information

Serial Number90766032
Word MarkOSO
Filing DateThursday, June 10, 2021
Status700 - REGISTERED
Status DateTuesday, March 12, 2024
Registration Number7329709
Registration DateTuesday, March 12, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 23, 2022
Primary Code042
First Use Anywhere DateTuesday, February 1, 2022
First Use In Commerce DateTuesday, February 1, 2022

Trademark Owner History

Party NameHollister Incorporated
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLibertyville, IL 60048
Party NameHollister Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLibertyville, IL 60048

Trademark Events

Event DateEvent Description
Monday, June 14, 2021NEW APPLICATION ENTERED
Tuesday, August 31, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 1, 2022ASSIGNED TO EXAMINER
Wednesday, March 2, 2022REMOVED FROM TEAS PLUS
Wednesday, March 2, 2022NON-FINAL ACTION WRITTEN
Wednesday, March 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 2, 2022NON-FINAL ACTION E-MAILED
Wednesday, March 2, 2022NON-FINAL ACTION WRITTEN
Wednesday, March 2, 2022NON-FINAL ACTION E-MAILED
Wednesday, March 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 4, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 4, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 4, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 23, 2022RESTORE TO TEAS PLUS
Monday, May 23, 2022NON-FINAL ACTION WRITTEN
Monday, May 23, 2022NON-FINAL ACTION E-MAILED
Monday, May 23, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 4, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 4, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 4, 2022TEAS AMENDMENT OF USE RECEIVED
Saturday, November 5, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, November 5, 2022USE AMENDMENT FILED
Saturday, November 5, 2022AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, January 30, 2024USE AMENDMENT ACCEPTED
Tuesday, January 30, 2024APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, January 31, 2024NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, March 12, 2024REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, March 12, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, November 14, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 14, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 14, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

field clinical trials information research medical scientific providing